Abstract
Purpose. The oral buccal mucosa may be an ideal site for mucosal immunization, allowing for the needle-free administration of cost-effective vaccines. A novel mucoadhesive bilayer film was developed to test the feasibility of this route of immunization in rabbits.
Methods. Bilayer films were developed using different ratios of Noveon and Eudragit S-100 as the mucoadhesive layer and a pharmaceutical wax as the impermeable backing layer. Optimal 3/8-inch films were post-loaded with 100 μg of plasmid DNA (CMV-β-gal) or β-galactosidase protein. The in vitro release rates and stability of the postloaded antigens were determined. The films were applied to the buccal pouch of rabbits on days 0, 7, and 14, and the humoral and splenocyte proliferative immune responses to β-gal were determined through day 28 and compared to those responses after conventional subcutaneous injection of adjuvanted protein.
Results. The weight ratio of Noveon and Eudragit S-100 had a significant effect on adhesion time of bilayer films. Postloaded plasmid DNA and β-gal remained stable after being released from bilayer films (release of ∼60-80% in 2 h for both). Buccal immunization using novel bilayer films (109 ± 6-μm thickness) containing plasmid DNA led to comparable antigen-specific IgG titer to that of subcutaneous protein injection. All rabbits immunized with plasmid DNA via the buccal route but none by the subcutaneous route with protein antigen demonstrated splenocyte proliferative immune responses.
Conclusion. The feasibility of buccal (genetic) immunization with these novel bilayer films was demonstrated.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
REFERENCES
A. W. Cripps, J. M. Kyd, and A. R. Foxwell. Vaccines and mucosal immunization. Vaccine 19:2513–2515 (2001).
J. R. McGhee and H. Kiyono. Mucosal immunity to vaccines: Current concepts for vaccine development and immune response analysis. In J.E. Ciardi (ed.), Genetically Engineered Vaccines. Plenum Press, New York, 1992 pp. 3–12.
K. Roy, H. Q. Mao, S. K. Huang, and K. W. Leong. Oral gene delivery wit chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allery. Nat. Med. 5:387–391 (1999).
K. Imaoka and C. J. Miller, M. Kubota, M. B. McChesney, B. Lohman, M. Yamamoto, K. Fujihashi, K. Someya, M. Honda, J. R. McGhee, G. Kiyono H. Nasal immunization of nonhuman primates with simian immunodeficiency virus p550 gag and cholera toxin adjuvant induced Th1/Th2 help for virus specific immune responses in reproductive tissue. J. Immunol. 161:5952–5958 (1998).
H. Shen, E. Goldberg, and W. M. Saltzman. Local DNA delivery polymer disks stimulate mucosal immunity in the vagina. The 28th International Symposium on Controlled Release of Bioactive materials, San Diego, California, June 23-27, (2001).
E. Ahlfors and C. Czerkinsky. Contact sensitivity in the murine oral mucosa. I. An experimental model of delayed-type hyper sensitivity reactions at mucosal surfaces. Clin. Exp. Immunol. 86:449–456 (1991).
A. W. Barret, A. T. Cruchley, and D. M. Williams. Oral mucosal Langerhans cells. Crit. Rev. Oral Biol. Med. 7:36 (1996).
J. R. McGhee, M. E. Lamn, and W. Strober. Mucosal immune responses: an overview. pp.485–506. In P. L. Orga, J. Mestechky, M. E. Lamn, W. Stober, J. Bienenstock, J. R. McGhee (eds.), Mucosal Immunology, 2nd edition, Academic Press, San Diego, California, 1999.
N. Etchart, R. Buckland, M. Liu, T. F. Wild, and D. Kaiserlian. Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J. Gen. Viol. 78:1577–1580 (1997).
P. Lundholm, Y. Asahura, J. Hinkula, E. Lucht, and B. Wahren. Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA. Vaccine 17:2036–2042 (1999).
J. Wang, T. Murakami, Y. Hakamata, T. Ajiki, Y. Jinbu, Y. Akasaka, M. Ohtsuki, H. Nakagawa, and E. Kobayashi. Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: Successful treatment of oral melanoma and distant skin lesion. Cancer Gene Ther. 8:705–712 (2001).
N. Etchart, P. Desmoulins, K. Chemin, C. Maliszewski, B. Dubois, F. Wild, and D. Kaiserlian. Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein. J. Immunol. 164:384–391 (2001).
J. A. Hoogstraate and P. W. Wertz. Drug delivery via the buccal mucosa. Pharm. Sci. Tech. Today 1:309–316 (1998).
S. Gurunathan, D. M. Klinman, and R. A. Seder. DNA vaccines: Immunology, application, and optimization. Annu. Rev. Immunol. 18:927–974 (2000).
Z. Cui and R. J. Mumper. Chitosan-based nanoparticles for topical genetic immunization. J. Control. Release 75:409–419 (2001).
Z. Cui and R. J. Mumper. Topical immunization using nanoengineered genetic vaccines. J. Control. Release 81:173–184 (2002).
D. Harris and J. R. Robinson. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 81:1–10 (1992).
The United States Pharmacopeia. (23)/The National Formulary (18), Unites States Pharmacopeial Convention, Inc. Rockville, Maryland (1995).
A. Wade and P. J. Weller. Handbook of Pharmaceutical Excipients, 2nd ed., American Pharmaceutical Association, Washington, and The Pharmaceutical Press, London (1994).
J. Holmgren, N. Lycke, and C. Czerhinsky. Cholera toxin and cholera toxin B-subunit as oral-mucosal adjuvant in antigen vector systems. Vaccine 11:1179–1184 (1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cui, Z., Mumper, R.J. Bilayer Films for Mucosal (Genetic) Immunization via the Buccal Route in Rabbits. Pharm Res 19, 947–953 (2002). https://doi.org/10.1023/A:1016454003450
Issue Date:
DOI: https://doi.org/10.1023/A:1016454003450